MOTHER'S DAY SPECIALS! SHOW ME MORE

Close Notification

Your cart does not contain any items

$184.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Churchill Livingstone
15 November 2024
In this issue of Urologic Clinics of North America, guest editors Drs. Onofrio Antonio Catalano and Michael Stanley Gee bring their considerable expertise to the topic of Urologic Tract Imaging. Technical advances in MRI, CT, and ultrasound, along with molecule-targeted radiopharmaceuticals and urinary contrast-based MRI and US, have transformed urologic tract imaging in recent years. In this issue, top experts review the principles of various novel imaging technologies, describe their application to the urinary tract, and provide imaging examples of normal anatomy and pathology.

Contains 13 relevant, practice-oriented topics, including morphologic urologic imaging; molecular urologic imaging; urologic imaging of congenital anomalies, infections, and inflammations; imaging of cancers and mimics; imaging of urologic trauma and urolithiasis; and much more. Provides in-depth clinical reviews on urologic tract imaging, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Edited by:   , , , , , ,
Imprint:   Churchill Livingstone
Country of Publication:   United Kingdom
Dimensions:   Height: 254mm,  Width: 178mm, 
Weight:   560g
ISBN:   9780443296086
ISBN 10:   0443296081
Series:   The Clinics: Surgery
Pages:   240
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

Onofrio Antonio Catalano, MD, PhD, is Associated Professor of Radiology at Harvard Medical School. Dr. Catalano has been working on PET/MR since its first clinical introduction in 2012, at first building the PET/MR program in Naples, Italy, and then at the MGH/Harvard, in Boston, as medical director. He has read thousands of PET/MR scans and is one of the world most prolific researchers on the field of PET/MR. Among several achievements, Dr. Catalano has been the first to demonstrate the utility of PET/MR in the clinical oncologic settings, and the first to show the capabilities of PET/MR in discriminating fibrotic from inflammatory stenoses in Crohn disease patients.

See Also